Effects of brevetoxins on murine myeloma SP2/O cells: aberrant cellular division.
Massive deaths of manatees (Trichechus manatus latirostris) during the red tide seasons have been attributed to brevetoxins produced by the dinoflagellate Karenia brevis (formerly Ptychodiscus breve and Gymnodinium breve). Although these toxins have been found in macrophages and lymphocytes in the lung, liver, and secondary lymphoid tissues of these animals, the molecular mechanisms of brevetoxicosis have not yet been identified. To investigate the effects of brevetoxins on immune cells, a murine myeloma cell line (SP2/O) was used as a model for in vitro studies. By adding brevetoxins to cultures of the SP2/O cells at concentrations ranging from 20 to 600 ng/ml, an apparent increase in proliferation was observed at around 2 hours post challenge as compared to the unchallenged cell cultures. This was followed by a drop in cell number at around 3 hours, suggesting an aberrant effect of brevetoxins on cellular division, the cells generated at 2 hours being apparently short-lived. In situ immunochemical staining of the SP2/O cells at 1 and 2 hour post challenge showed an accumulation of the toxins in the nucleus. A 21-kDa protein was subsequently isolated from the SP2/O cells as having brevetoxin-binding properties, and immunologically identified as p21, a nuclear factor known to down-regulate cellular proliferation through inhibition of cyclin-dependent kinases. These data are the first on a possible effect of brevetoxins on the cell cycle via binding to p21, a phenomenon that needs to be further investigated and validated in normal immune cells.
Han
Thomas K
TK
Department of Biology, University of South Florida, Tampa, Florida 33620-5150, USA.
Derby
Melissa
M
Martin
Dean F
DF
Wright
Scott D
SD
Dao
My Lien
ML
D000818:Animals; D015153:Blotting, Western; D002352:Carrier Proteins / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects; D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins / Q000378:metabolism; D004141:Dinoflagellida; D004305:Dose-Response Relationship, Drug; D007150:Immunohistochemistry; D008387:Marine Toxins / Q000276:immunology / Q000378:metabolism / Q000633:toxicity*; D051379:Mice; D035964:Oxocins / Q000276:immunology / Q000378:metabolism / Q000633:toxicity*; D010954:Plasmacytoma / Q000473:pathology*; D020455:Trichechus; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D000095702:Polyether Toxins
D002352:Carrier Proteins; D050759:Cyclin-Dependent Kinase Inhibitor p21; D016213:Cyclins; D008387:Marine Toxins; D035964:Oxocins; C493957:Cdkn1a protein, mouse; C053342:brevetoxin; D000095702:Polyether Toxins